Imipramine Pamoate (Avera McKennan Hospital)


Welcome to the PulseAid listing for the Imipramine Pamoate drug offered from Avera McKennan Hospital. This Tricyclic Antidepressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: Imipramine Pamoate
SUBSTANCE NAME: IMIPRAMINE PAMOATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Tricyclic Antidepressant [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-02-15
END MARKETING DATE: 0000-00-00


Imipramine Pamoate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionImipramine Pamoate from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 75(mg/1)
START MARKETING DATE: 2016-02-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-0525_523f08c4-c104-4f3c-9e0e-71bc612f6a2c
PRODUCT NDC: 69189-0525
APPLICATION NUMBER: ANDA091099

Other IMIPRAMINE PAMOATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalImipramine Pamoate
LUPIN LIMITEDImipramine Pamoate
Lupin Pharmaceuticals, Inc.Imipramine Pamoate
STAT RX USA LLCIMIPRAMINE PAMOATE
West-Ward Pharmaceuticals Corp.Imipramine Pamoate